Aurélie Bertaut

3.3k total citations
105 papers, 1.8k citations indexed

About

Aurélie Bertaut is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Aurélie Bertaut has authored 105 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 40 papers in Pulmonary and Respiratory Medicine and 27 papers in Surgery. Recurrent topics in Aurélie Bertaut's work include Colorectal Cancer Treatments and Studies (22 papers), Cancer Treatment and Pharmacology (15 papers) and Breast Cancer Treatment Studies (14 papers). Aurélie Bertaut is often cited by papers focused on Colorectal Cancer Treatments and Studies (22 papers), Cancer Treatment and Pharmacology (15 papers) and Breast Cancer Treatment Studies (14 papers). Aurélie Bertaut collaborates with scholars based in France, Italy and Switzerland. Aurélie Bertaut's co-authors include François Ghiringhelli, G. Créhange, Emeric Limagne, Nicolás Isambert, Valentin Dérangère, Corentin Richard, Julie Blanc, Céline Mirjolet, Romain Boidot and Marion Thibaudin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Aurélie Bertaut

97 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurélie Bertaut France 24 838 590 357 330 303 105 1.8k
J. Doyen France 22 716 0.9× 661 1.1× 520 1.5× 294 0.9× 143 0.5× 101 1.9k
Vincent van der Noort Netherlands 23 1.3k 1.5× 1.4k 2.5× 266 0.7× 286 0.9× 294 1.0× 133 2.5k
Pol Specenier Belgium 21 1.1k 1.3× 542 0.9× 624 1.7× 287 0.9× 206 0.7× 84 1.9k
Katja Lindel Germany 22 708 0.8× 466 0.8× 322 0.9× 610 1.8× 56 0.2× 60 1.9k
Hendrik A. Wolff Germany 31 1.2k 1.4× 835 1.4× 632 1.8× 828 2.5× 115 0.4× 106 2.6k
Jenny Huang United States 10 431 0.5× 350 0.6× 406 1.1× 255 0.8× 120 0.4× 19 1.4k
Giovanna Masci Italy 21 789 0.9× 376 0.6× 471 1.3× 121 0.4× 102 0.3× 73 1.6k
Vinita Takiar United States 21 370 0.4× 468 0.8× 487 1.4× 362 1.1× 71 0.2× 100 1.6k
S Hellman United States 13 806 1.0× 411 0.7× 453 1.3× 325 1.0× 275 0.9× 23 1.9k
Ewa Sierko Poland 20 662 0.8× 305 0.5× 475 1.3× 172 0.5× 155 0.5× 81 1.6k

Countries citing papers authored by Aurélie Bertaut

Since Specialization
Citations

This map shows the geographic impact of Aurélie Bertaut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Bertaut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Bertaut more than expected).

Fields of papers citing papers by Aurélie Bertaut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Bertaut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Bertaut. The network helps show where Aurélie Bertaut may publish in the future.

Co-authorship network of co-authors of Aurélie Bertaut

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Bertaut. A scholar is included among the top collaborators of Aurélie Bertaut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Bertaut. Aurélie Bertaut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bertaut, Aurélie, Alice Hervieu, Sylvie Zanetta, et al.. (2025). FOLFIRINOX-3 plus bevacizumab (bFOLFIRINOX3) in chemo-refractory metastatic colorectal cancer: a multicenter phase II trial. Future Oncology. 21(6). 699–706. 3 indexed citations
3.
Bertaut, Aurélie, Sylvain Ladoire, Isabelle Desmoulins, et al.. (2024). HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity. Cancers. 16(11). 2009–2009. 1 indexed citations
4.
Zilli, Thomas, Ciro Franzese, Matthias Gückenberger, et al.. (2024). ONE SHOT - single shot radiotherapy for localized prostate cancer: 18-month results of a single arm, multicenter phase I/II trial. Radiotherapy and Oncology. 194. 110181–110181. 4 indexed citations
5.
Bessières, Igor, et al.. (2023). Online adaptive radiotherapy and dose delivery accuracy: A retrospective analysis. Journal of Applied Clinical Medical Physics. 24(8). e14005–e14005. 1 indexed citations
6.
Arnould, Laurent, Françoise Beltjens, Didier Mayeur, et al.. (2023). Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy. Breast Cancer. 30(6). 997–1007. 8 indexed citations
7.
Ladoire, Sylvain, et al.. (2023). Performance of [18F]FDG-PET/CT Imaging in First Recurrence of Invasive Lobular Carcinoma. Journal of Clinical Medicine. 12(8). 2916–2916. 5 indexed citations
8.
Edeline, Julien, Satoshi Hirano, Aurélie Bertaut, et al.. (2022). Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studies. European Journal of Cancer. 164. 80–87. 14 indexed citations
9.
MacGrogan, Gaëtan, Aurélie Bertaut, Sylvain Ladoire, et al.. (2021). Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations. Modern Pathology. 34(7). 1282–1296. 23 indexed citations
10.
Beltjens, Françoise, Aurélie Bertaut, Corentin Richard, et al.. (2021). ER−/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple‐negative breast cancer. International Journal of Cancer. 149(1). 200–213. 17 indexed citations
11.
12.
Blanc, Julie, et al.. (2020). Influence of primary tumor location and resection on survival in metastatic colorectal cancer. World Journal of Gastrointestinal Oncology. 12(11). 1296–1310. 7 indexed citations
13.
Bertaut, Aurélie, Mélanie Dore, L. Claude, et al.. (2020). Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation. Radiation Oncology. 15(1). 82–82. 32 indexed citations
14.
15.
Cortet, Marion, Tienhan Sandrine Dabakuyo‐Yonli, Ludivine Launay, et al.. (2017). Breast cancer subtype of French women is not influenced by socioeconomic status: A population-based-study. PLoS ONE. 12(2). e0170069–e0170069. 9 indexed citations
16.
Chevallier, Olivier, Aurélie Bertaut, E. Delorme, et al.. (2017). Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction. Quantitative Imaging in Medicine and Surgery. 7(1). 8–23. 39 indexed citations
17.
18.
Bertaut, Aurélie, Mireille Folia, C. Duvillard, et al.. (2016). Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy. Clinical and Translational Radiation Oncology. 1. 27–32. 4 indexed citations
19.
Gobbo, Jessica, Guillaume Marcion, Marine Cordonnier, et al.. (2015). Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer. JNCI Journal of the National Cancer Institute. 108(3). djv330–djv330. 171 indexed citations
20.
Volatier, Jean‐Luc, et al.. (2013). Characteristics of energy intake under-reporting in French adults. British Journal Of Nutrition. 111(7). 1292–1302. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Doyen Breakdown of academic impact, for papers by Vincent van der Noort Breakdown of academic impact, for papers by Pol Specenier Breakdown of academic impact, for papers by Katja Lindel Breakdown of academic impact, for papers by Hendrik A. Wolff Breakdown of academic impact, for papers by Jenny Huang Breakdown of academic impact, for papers by Giovanna Masci Breakdown of academic impact, for papers by Vinita Takiar Breakdown of academic impact, for papers by S Hellman Breakdown of academic impact, for papers by Ewa Sierko
Rankless by CCL
2026